Physician profile
Eva Welch
NPI 1780070193
$3,913.38
in general payments reported to CMS, 2019-2025
9 companies · $1,022 in 2025
The $1,022 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $133 · 2021: $1,185 · 2022: $60.97 · 2023: $591 · 2024: $760 · 2025: $1,022.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,872 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,872.13 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,227.13 | 2019-2025 | Altis, Restorelle |
| Intuitive Surgical, INC. | $1,055.79 | 2021-2022 | |
| Boston Scientific Corporation | $583.58 | 2021-2025 | Advantage System, Upsylon, Solyx Sis System |
| Momentis Surgical INC. | $500.00 | 2025 | |
| Axonics, INC. | $292.17 | 2022-2024 | Axonics |
| Renovia INC | $143.51 | 2019 | |
| Bluewind Medical | $54.30 | 2025 | Revi |
| Applied Medical Resources Corporation | $31.90 | 2023 | |
| Femselect INC. | $25.00 | 2024 | Enplace |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.